View Older Stories View More Recent Stories

Feb 11, 2025 08:18AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Our Expert Sees A Favorable Set-up'
Feb 3, 2025 05:11AM Goldman Makes Monthly Adjustment to Director's Cut Conviction List
Jan 14, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jan 13, 2025 12:21PM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) After a Solid TTR Beat
Jan 13, 2025 11:20AM Alnylam Pharma (ALNY) Announces Preliminary Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance
Dec 22, 2024 04:00AM Barclays shares outlook for Biotech in 2025, names preferred stocks
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Nov 26, 2024 06:52AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Nov 25, 2024 08:23AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Nov 25, 2024 07:01AM Alnylam Pharma (ALNY) Announces U.S. FDA Acceptance of sNDA for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Nov 19, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Nov 18, 2024 08:56AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Nov 12, 2024 04:54AM Wolfe Research Downgrades Alnylam Pharmaceuticals (ALNY) to Underperform
Nov 4, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 31, 2024 08:05AM Alnylam Pharma (ALNY) Tops Q3 EPS by 43c, Misses on Revenue; Offers FY24 Guidance
Oct 24, 2024 06:23AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 21, 2024 08:21AM Alnylam Pharmaceuticals (ALNY) PT Raised to $371 at TD Cowen
Oct 18, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 16, 2024 08:04AM Alnylam Pharma (ALNY) Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Oct 11, 2024 06:20AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 08:21AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 07:56AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 07:43AM Piper Sandler Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 06:25AM Oppenheimer Reiterates Perform Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 05:50AM Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 05:36AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2024 05:30AM BofA Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 9, 2024 07:03AM Alnylam Pharma (ALNY) Submits sNDA to FDA for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy
Oct 1, 2024 06:49AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 30, 2024 08:35AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 30, 2024 07:52AM Piper Sandler Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Sep 30, 2024 05:42AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 27, 2024 06:01AM BofA Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 16, 2024 08:41AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 4, 2024 05:22AM Alnylam Pharmaceuticals (ALNY) PT Raised to $307 at BofA Securities
Sep 3, 2024 08:05AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 07:37AM Oppenheimer Reiterates Perform Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 07:29AM Wolfe Research Reiterates Peerperform Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 07:24AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 05:25AM Barclays Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Sep 3, 2024 05:18AM Citi Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Aug 30, 2024 08:50AM Alnylam Pharma (ALNY) Management Said There Was a Typo Error on Discussant Slide - Stat
Aug 30, 2024 08:21AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY) following HELIOS-B readout
Aug 30, 2024 07:58AM Stifel Reiterates Alnylam Pharmaceuticals (ALNY) at Buy following HELIOS-B readout, 'full HELIOS-B data look strong'
Aug 30, 2024 07:39AM Ainylam Pharmaceuticals shares tumble following study results, BridgeBio Pharma rises
Aug 30, 2024 06:11AM Alnylam Pharma (ALNY) Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran
Aug 27, 2024 07:47AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Aug 26, 2024 06:27AM RBC Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Aug 16, 2024 08:49AM Goldman Sachs Upgrades Alnylam Pharmaceuticals (ALNY) to Buy
View More Recent Stories View Older Stories